Cardiometabolic disease risk begins in early life and tracks through the life course. As described in "Sex-specific trajectories of measures of cardiovascular health during childhood and adolescence: a prospective cohort study" (O'Keeffe et al., 2018), we modelled sexspecific change in 11 key measures of cardiovascular health from birth/early childhood to age 18 years in a British birth cohort study, the Avon Longitudinal Study of Parents and Children (ALSPAC). In this article, we describe the data used in these analyses. Risk factors measured included BMI, fat and lean mass, blood pressure and blood-based biomarkers. Data are from several sources including cord blood at birth, clinic assessments, routine health records, questionnaires and nuclear magnetic resonance spectroscopy. Outcomes were measured over varying time spans from birth or mid-childhood to age 18 and with different numbers of repeated
measures per outcome. Analyses were performed using fractional polynomial and linear spline multilevel models. Further information can be found in O'Keeffe et al. (2018 
Value of the data
Repeated measures of 11 key measures of cardiovascular health have been analyzed and trajectories of these are available for use as exposures or outcomes to address other research questions.
These trajectories may also be useful in comparative work with other cohorts to better understand change in measures of cardiovascular health during childhood and adolescence, their determinants and associations with outcomes in later life.
Modelling strategies used for these data may also be useful for others who wish to examine change over time in risk factors, where multiple repeat measures are available.
Data
The data shared here are tables and figures of analyzed data from the Avon Longitudinal Study of Parents and Children (ALSPAC). The ALSPAC is a prospective birth cohort study in Southwest England and is described elsewhere in detail [1] [2] [3] . In summary, pregnant women resident in Avon, UK with expected dates of delivery 1st April 1991 to 31st December 1992 were invited to take part in the study. Of the 14,541 initial pregnancies, there was a total of 14,676 foetuses, resulting in 14,062 live births and 13,988 children who were alive at 1 year of age. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Data was available for 11 measures of cardiovascular health from birth or mid-childhood to 18 years. Data on the number, timing and sources of measures are detailed elsewhere [1] [2] [3] [4] [5] [6] [7] . A comprehensive profiling of offspring circulating lipids, lipoproteins, and metabolites was done by a high-throughput nuclear magnetic resonance (NMR) metabolomics platform, providing a snapshot of offspring serum metabolome [8, 9] . Non-fasting glucose at age seven from NMR was included in these analyses. Data were analyzed by sex from birth to 18 years. Model fit statistics for analyses performed, characteristics of participants included and excluded from analyses, mean sex-specific trajectories of each measure of cardiovascular health and results from sensitivity analyses are included in this paper.
Experimental design, materials and methods

Study population
The ALSPAC has been described elsewhere in detail [1] [2] [3] . The study website contains details of all the data that is available through a fully searchable data dictionary http://www.bristol.ac.uk/alspac/ researchers/our-data/ [4] .
Methods and statistical analysis
Two approaches, linear splines and fractional polynomials multilevel models were used in the modelling of trajectories of measures of cardiovascular health [1, [10] [11] [12] [13] .
We derived appropriate powers of height adjustment for DXA-determined fat and lean mass which were age and sex-specific and included these in multilevel models (Table 1) . Observed and predicted measurements for models are shown in Tables 2-12 . We examined the characteristics of mothers of participants included in the analysis of insulin (outcome measured on the fewest participants and with fewest repeated measures) compared with mothers of participants excluded from our analysis (Table 13 ). The mean sex-specific trajectories of measures of cardiovascular health are shown in Tables 14-17 . We also regressed the observed risk factor at the first occasion of measurement and last occasion of measurement (18 years) on sex to examine whether sex differences estimated from the multilevel model at these ages were comparable to the observed data (Table 18) . We restricted the sample for each risk factor to those with at least one measure before and one after the 11-year clinic, to examine whether results from the main analysis were driven by participants with only a single pre-or post-puberty measure (Figs. 1-4) . We repeated analyses of BMI restricted to participants with more than six measures to examine if results were driven by participants with a greater number of measures (Fig. 5) . We also repeated analyses excluding the observations of participants at the 15-and 18-year clinics who reported eating in the four hours preceding these clinics to examine if our results were altered by the inclusion of some non-fasted bloods (Figs. 6 and 7). Glucose at age 15 and 18 from the NMR platform was compared with glucose from standard clinical chemistry assays at these ages to examine the comparability of NMR and clinical chemistry measures (Table 19) . a BMI is modelled using fractional polynomials. For ease of interpretation, the predicted log BMI for females and males is shown at each age rather than the coefficients for the fractional polynomial terms from the model. b The difference between females and males for BMI and fat mass is back transformed from the log scale for ease of interpretation and is interpreted as the percentage difference in the mean level comparing females with males or percentage difference in change per year comparing females with males. 
Table 17
Mean sex-specific trajectories of log triglyceride and cholesterol estimated from multilevel models N=8,510 N=6,502 N=6,517 Fig. 1 . Mean predicted sex-specific trajectories of BMI (1 to 18 years), height-adjusted fat mass and height-adjusted lean mass (9 to 18 years) among participants with at least one measure before and after 11 years.
N=7,264
N=7,264 N=7,264
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome. DBP, diastolic blood pressure; SBP, systolic blood pressure. Fig. 2 . Mean predicted sex-specific trajectories of SBP, DBP and pulse from 7 to 18 years among participants with at least one measure before and after 11 years.
N=2,979
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome Fig. 3 . Mean predicted sex-specific trajectories of glucose from 7 to 18 years among participants with at least one measure before and after 11 years.
N=3,969
N=3,990 N=3,982
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome. HDL-c, high density lipoprotein cholesterol Fig. 4 . Mean predicted sex-specific trajectories of triglyceride, HDL-c and non-HDL-c from birth to 18 years among participants with at least one measure before and after 11 years.
N=8,247
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome 
N=7,159 N=662
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome Fig. 6 . Mean predicted sex-specific trajectories of glucose (7 -18 years) and insulin (birth -18 years) excluding participants who reported eating before either the 15-or 18-year clinic.
N=10,074 N=10,060 N=10,043
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome. HDL-c, high density lipoprotein cholesterol 
